OptiGlycemiX Chocolate Mint®

Suggested/Recommended/Usage/Directions

DIRECTIONS: Blend, shake, or briskly stir two level scoops (57 g) of OptiGlycemiX(TM) into 8-12 oz chilled water and consume one to two times daily; or take one to two scoops approximately 30 minutes before each main meal (upper limit of six scoops/day); or use as directed by your healthcare practitioner.

Storage

STORAGE: Keep tightly closed in a cool, dry place.

Formula re: Type

OptiGlycemiX is a research-based functional food formulated to nutritionally support individuals with insulin/glucose dysregulation and related health issues. It features InSea2(R) - a clinically tested, optimized blend of purified polyphenols from wild-crafted brown seaweed. InSea2 uniquely slows carbohydrate digestion and assimilation and can reduce the impact of high-glycemic foods, resulting in more appropriate glucose and insulin responses. This newly developed, next generation dual carb controller is 100% natural, has an excellent safety profile, and is friendly to the gastrointestinal tract.* OptiGlycemiX also delivers other innovative ingredients, including VegaPro(TM) - a proprietary, sugar-free, sweetener-free, low-allergy-potential source of vegetable protein from pea protein isolate and rice protein concentrate – and CinSulin(R), a concentrated, patented water extract of cinnamon with a potent 10:1 yield ratio. Cinnamon has been studied extensively for its roles in glucose uptake, glycogen synthesis, insulin action, and support for healthy blood lipids. These principal ingredients are complemented by the inclusion of thiamin (as benfotiamine) to boost transketolase activity; alpha-lipoic acid (ALA); green tea leaf extract; vanadium, chromium, and zinc as Albion(R) TRAACS(R) chelates; 5-MTHF (bioactive folate) as Quatrefolic(R); fiber from inulin; and other key vitamins and minerals.* This exclusive combination of well-researched, clinically validated, and highly bioavailable ingredients employs a multi-modal defense against factors that cause blood glucose to rise too quickly, insulin sensitivity to decrease, glycation and oxidative stress to escalate, fat storage to increase, and blood lipids to become altered.*

Formulation re: Does NOT Contain

DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, artificial sweeteners, or preservatives.

Formula re: Type

Functional Food for Individuals With Insulin/Glucose Dysregualtion Featuring InSea2(R) - Next Generation Carbohydrate Control*

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

General Statements: All Other Content

EXCLUSIVE PROFESSIONAL FORMULAS

Brand IP Statement(s) re: (c), (TM), (SM)

Quatrefolic is a registered trademark of Gnosis S.p.A. Patents Pending.

General Statements: All Other Content

21g PROTEIN

General Statements: All Other Content

FUNCTIONAL FOOD

General Statements: All Other Content

This package is completely recyclable (recycle)

Brand IP Statement(s) re: (c), (TM), (SM)

XYMOGEN 2011

Brand IP Statement(s) re: (c), (TM), (SM)

Albion(R) and TRAACS(R) are registered trademarks of Albion Laboratories, Inc. Chelates covered by U.S. Patent 7,838,042 and patents pending.

Brand IP Statement(s) re: (c), (TM), (SM)

All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.

Brand IP Statement(s) re: (c), (TM), (SM)

CinSulin(R) is a registered trademark of Tang-An Medical Ltd., manufactured under U.S. Patent 6,200,569.

Brand IP Statement(s) re: (c), (TM), (SM)

InSea2(R) is a registered trademark of innoVactiv Inc.

Seals/Symbols

Quatrefolic(TM)

Seals/Symbols

V VegaPro(TM) 100% VEGAN 100% Gluten Free

General: Product/Version Code

REV. 100411